STARTRADER Introduces 24/7 US Stock CFDs Across NVIDIA, Apple, Meta, and Leading Global Equities
STARTRADER today launches 42 new 24/5 US Stock CFDs and announces the introduction of 43 new 24/7 US Stock CFDs from 27 July 2026, expanding its offering to 85 new instruments. DUBAI, UAE, July 22, 2026 /PRNewswire/ -- STARTRADER today announced the...
Ericsson announces change to the Executive Team
Christophe Van de Weyer, currently Head of Business Unit API at Vonage, to become Head of Business Area Global Communications Platform and CEO of Vonage Niklas Heuveldop to step down on August 15, and remain available up to December 31, 2026, to...
WORLD FOOD & MUSIC FESTIVAL ANNOUNCES 2026 FOOD VENDORS, MERCHANTS AND NONPROFITS
GREATER DES MOINES, Iowa, July 21, 2026 /PRNewswire/ -- The World Food & Music Festival presented by Veridian Credit Union has announced food vendors, merchants and nonprofits participating in the 2026 Festival taking place Friday, Aug. 28 –...
B&R Technology Merger Corp. Announces Pricing of $325 Million Initial Public Offering
NEW YORK, July 21, 2026 /PRNewswire/ -- B&R Technology Merger Corp. (the "Company") announced the pricing of its initial public offering of 32,500,000 units at $10.00 per unit. The units will be listed on the Nasdaq Global Market ("Nasdaq")...
Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)
DEEp OCEAN is a global trial designed to evaluate the investigational molecule bexicaserin for the treatment of seizures associated with DEEs, a diverse group of childhood-onset epilepsies1 Broadest pivotal trial to date, enrolling patients with a...
Samsung Biologics announces all-cash offer to acquire PolyPeptide, accelerating multi-modality strategy and expanding global network across U.S., Europe, and India
Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury shares) at CHF 44.31 per share, representing an equity value of approximately CHF 1.46 billion....
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30
- ASC48 is a potentially first-in-class oral small molecule GIPR agonist. - ASC48 demonstrated an EC 50 of 1 pM in the hGIPR cAMP activation assay, exhibiting greater potency than tirzepatide (EC 50 = 3 pM) and is a selective agonist for GIPR...
M Social Hotel Sunnyvale announces Key Leadership Appointments ahead of Fall 2026 debut
SILICON VALLEY, Calif., July 14, 2026 /PRNewswire/ -- M Social Hotel Sunnyvale, the new lifestyle hotel owned by Millennium Hotels and Resorts, set to debut in the heart of Silicon Valley in Fall 2026, is pleased to announce the appointments of...
Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB
SHANGHAI and HONG KONG, July 13, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class...
Elong Power Holding Limited Announces Pricing of US$6.6 Million Public Offering
BEIJING, July 10, 2026 /PRNewswire/ -- Elong Power Holding Limited (Nasdaq: ELPW) ("Elong Power" or the "Company"), a comprehensive provider dedicated to the R&D, sales and scenario-oriented system solutions of lithium-ion battery energy storage...